Literature DB >> 9195568

Vascular adrenal cysts: a clinicopathologic and immunohistochemical study of six cases and a review of the literature.

C Torres1, J Y Ro, M A Batt, Y W Park, N G Ordonez, A G Ayala.   

Abstract

The clinical, histologic, and immunohistochemical features of six cases of hemorrhagic adrenal pseudocysts are reported together, with a review of the English literature on this topic since 1950. The mean age at presentation was 57 years (range, 30-72 yr). There were four men and 2 women. The average cyst size was 9.2 cm (range, 6-16 cm). In four patients, the hemorrhagic adrenal pseudocysts were incidental findings. The remaining two patients presented with an abdominal mass and hypertension, respectively. The hemorrhagic pseudocysts were unilocular cystic masses surrounded by a fibrous capsule and containing abundant amorphous material, blood, and fibrin. Numerous dilated, thin-walled, vascular channels that stained strongly for Factor VIII-related antigen, collagen IV, laminin, Ulex europaeus agglutinin I lectin, and CD34 were present within the fibrous capsule, cyst contents, and surrounding residual adrenal gland. These findings support a vascular origin for these lesions, and they are thought, therefore, to be related to endothelial adrenal cysts. The literature review of 111 vascular adrenal cysts (85 hemorrhagic pseudocystic type and 26 endothelial type) showed similar clinical features. The mean age at presentation was 44.5 years (range, 5 d-95 yr), with a female predominance (62%). The most common clinical presentation was abdominal pain (35%), followed by incidental findings (32%). There were no significant clinical differences between hemorrhagic and endothelial type cysts. In some cases, the presence of intracystic islands of cortical cells can cause diagnostic confusion with adrenal cortical tumors. The presence, however, of a rich intracystic and capsular vascular network, normal-appearing islands of cortical cells, and abundant thrombotic fibrinous material, rather than necrotic tumor cells, should rule out the possibility of a degenerating adrenal cortical neoplasm.

Entities:  

Mesh:

Year:  1997        PMID: 9195568

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Hemorrhagic adrenal pseudocyst: laparoscopic treatment.

Authors:  H A Amarillo; M Bruzoni; M Loto; G H Castagneto; M E Mihura
Journal:  Surg Endosc       Date:  2004-08-24       Impact factor: 4.584

3.  Cystic lymphangioma of the right adrenal gland.

Authors:  Lora Esberk Ates; Yersu Kapran; Yesim Erbil; Umut Barbaros; Ferhunde Dizdaroglu
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

4.  Adrenal Pseudocysts: Evidence of Their Posthemorrhagic Nature.

Authors:  Timothy A. Jennings; Bernard Ng; Ann Boguniewicz; Muzaffar Khan; Donald Rice; James Figge
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

Review 5.  Adrenal cystic lesions: a clinicopathological analysis of 25 cases with proposed histogenesis and review of the literature.

Authors:  Hui-Ping Chien; Yu-Sun Chang; Pei-Sung Hsu; Jen-Der Lin; Yi-Chin Wu; Hui-Lang Chang; Cheng-Keng Chuang; Ke-Hung Tsuei; Chuen Hsueh
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

6.  Adrenal pseudocyst mimicking cancer: a case report.

Authors:  S Bovio; F Porpiglia; E Bollito; B Allasino; G Reimondo; E Rovero; L Perazzolo; A Angeli; M Papotti; M Terzolo
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

7.  Adrenal lymphangioma removed by a retroperitoneoscopic procedure.

Authors:  Ben Liu; Yanyuan Li; Shuo Wang
Journal:  Oncol Lett       Date:  2012-12-04       Impact factor: 2.967

8.  Laparoscopic Management of a Complex Adrenal Cyst.

Authors:  Koichi Kodama; Yasukazu Takase; Susumu Niikura; Akiko Shimizu; Hiroki Tatsu; Katsuhiko Saito
Journal:  Case Rep Urol       Date:  2015-11-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.